pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
RGDCRAdcox-2F
Pancreatic Cancer
University of Minnesota
0 catalysts
Preclinical
RGN-6024
Glioblastoma Multiforme (GBM)
Reglagene Holding Inc
0 catalysts
Phase 1
RGT-61159
Adenoid Cystic Carcinoma (ACC)
Rgenta Therapeutics Inc
0 catalysts
Phase 1
RGVax
← prev
page 32 of 62
next →
131
Pain89
Neurology1
Human Papillomavirus (HPV) Associated Cancer
Pathovax LLC
0 catalysts
Preclinical
RK-33
Triple-Negative Breast Cancer (TNBC)
Natsar Pharmaceuticals Inc
0 catalysts
Phase 2
RNK-05047
Diffuse Large B-Cell Lymphoma
Ranok Therapeutics Co Ltd
0 catalysts
Phase 1
ROSE-12
Solid Tumor
Chugai Pharmaceutical Co Ltd
0 catalysts
Preclinical
RP-001
Breast Cancer
Recurv Pharma Inc
0 catalysts
Phase 2
RP-323
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
PhorMed Inc
0 catalysts
Preclinical
RS-5
Soft Tissue Sarcoma
Resolute Science Inc
0 catalysts
Phase 2
RV-01
Castration-Resistant Prostate Cancer (CRPC)
Radiopharm Ventures LLC
0 catalysts
Phase 2
RX-0301
Hepatocellular Carcinoma
Zhejiang Haichang Biotechnology Co Ltd
0 catalysts
Phase 2
RZ-001
Glioblastoma Multiforme (GBM)
Rznomics Inc
0 catalysts
Phase 2
Radspherin
Colorectal Cancer
Oncoinvent ASA
0 catalysts
Marketed
Regenecyte
Blood Cancer
StemCyte Inc
0 catalysts
Marketed
Rylaze
Rylaze (asparaginase erwinia chrysanthemi-rywn)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$JAZZJazz Pharmaceuticals plc
0 catalysts
Phase 2
S-531011
Adenocarcinoma Of The Gastroesophageal Junction
$SGIOFSHIONOGI & CO LTD
0 catalysts
Phase 2
SA-53
Dedifferentiated Liposarcoma
Lamassu Bio Inc
0 catalysts
Phase 1
SACT-1
Neuroblastoma
$APMAptorum Group Ltd
0 catalysts
Phase 2
SAF-189
Non-Small Cell Lung Cancer
Fochon Pharmaceutical Ltd
0 catalysts
Phase 1
SAR-446523
Refractory Multiple Myeloma
$SNYSanofi
0 catalysts
Preclinical
SAR-BBN
Metastatic Breast Cancer
Clarity Pharmaceuticals Ltd
0 catalysts
Phase 2
SB-11285
Cervical Cancer
invoX Pharma Ltd
0 catalysts
Phase 1
SBE-303
Solid Tumor
Samsung Bioepis Co Ltd
0 catalysts
Preclinical
SBI-1301
Prostate Cancer
Soricimed Biopharma Inc
0 catalysts
Phase 1
SBO-154
Breast Cancer
Sun Pharma Advanced Research Company Ltd
0 catalysts
Preclinical
SBT-100
Osteosarcoma
Singh Biotechnology LLC
0 catalysts
Preclinical
SC-134
Small-Cell Lung Cancer
Scancell Holdings Plc
0 catalysts
Phase 1
SCDARIC-33
Refractory Acute Myeloid Leukemia
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 2
SCG-101
Hepatocellular Carcinoma
SCG Cell Therapy Pte Ltd
0 catalysts